Preclinical study demonstrates reduced colitis-associated colorectal cancer following early Wumei Wan administration in disease models, highlighting stage-dependent myeloid-derived cell suppression.
Wumei Wan (WMW), a traditional Chinese medicine prescription, has been proved to be effective in treating Colitis-associated colorectal cancer (CAC), but it has not been proven to be effective in different stages of CAC.
No takes yet. Share an insight, caveat, or question.
Lü et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: